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Biomedical Ethics Policy in Korea: Characteristics and Historical 
Development
Ethical consideration is an inseparable part of policy-making in modern society. Biomedical 
ethics is an interdisciplinary study of ethical issues that result from advances in medical 
practices and research. Because these issues often arise at the bedside, society must 
provide solutions or judgments that are effective and applicable. Thus, the development 
and progress of biomedical ethics has been made possible via the cooperation of experts 
from diverse backgrounds. The biomedical ethics discourse should not be seen as a conflict 
between values but as a collective activity for problem-solving. To support this perspective 
on ethics discourse, a historical perspective on biomedical ethics in Korea was given 
emphasis on the participants and their perspectives. Major cases and the changes resulting 
therefrom were discussed with the agenda proposed. The Korean situation with respect to 
ethics development shows the interactions between groups participating in policy 
development and its collaborative nature. 
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ORIGINAL ARTICLE
INTRODUCTION
Ethical consideration is an inseparable part of policy-making 
in modern society. What is ethics and how do ethical consider-
ations affect decision-making? The Korean situation with re-
spect to ethics development shows the interactions between 
groups participating in policy development and its collabora-
tive nature. 
 Biomedical ethics (or bioethics and medical ethics) is an in-
terdisciplinary study of the ethical issues that result from ad-
vances in medical practices and research. Its interdisciplinary 
character comes from the very fact that these issues are not only 
new to society but also radical and controversial. And because 
the issues actually arise at the bedside, society must provide 
solutions or judgments that are effective and applicable. Thus, 
the development and progress of biomedical ethics has been 
made possible via the cooperation of experts from diverse back-
grounds, such as medicine, bioscience, ethics, theology, legal 
studies, and public policy. 
 This article will discuss the historical development of Korean 
biomedical ethics with current participants in biomedical eth-
ics discourse and their perspectives, as well as the major cases 
and the changes they brought about in social and policy. This 
historical perspective will show that biomedical ethics is an in-
terdisciplinary study that calls for more active participation and 
interest from the medical professional as well as other related 
fields of study. 
DEVELOPMENT OF KOREAN BIOMEDICAL ETHICS: 
HISTORICAL PERSPECTIVES 
Scope of biomedical ethics discourse 
The work of biomedical ethics is focused on these goals: first to 
provide priority or process for deliberation in healthcare policy-
making, and second to set up a standard of legitimate expecta-
tions for professional behavior by identifying basic attitudes and 
competence. But biomedical ethics is not a single discipline. 
The term “biomedical ethics” itself is a coinage of “bioethics” 
and “medical ethics”. The subjects and methodologies in bio-
ethics and medical ethics are usually the same, but the scope 
and goals are not identical. Medical ethics, more specifically, 
takes the role of providing ideals and standards of behaviors and 
attitudes to medical professional while protecting professional 
autonomy from societal intervention (1-3). Bioethics is mainly 
non-professional engagement in issues of medicine and medi-
cal research for the protection of human participants and soci-
ety’s values (4). This distinction is essential from the start to have 
a better understanding of the current discussion concerning 
biomedical ethics. 
Ethics tradition of Korean medical professionals: ideals & 
education  
The medical professional has a long tradition of ethics in Korea. 
Traditional Korean doctors of the Chosun dynasty (14c-19c) were 
under the influence of Confucianism, which emphasized social 
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positions and the mutual responsibilities of each person. The 
responsibilities of Confucian physicians can be found in Ui-Bang-
Yu-Chui (醫方類聚; A Collection of Medical Procedures), which 
identified a physician’s duty to treat sickness, to act in the pa-
tient’s best interest, to promote philanthropy, and to refrain from 
undue financial gain. Although Korea’s traditional biomedical 
ethics can be traced back at least to the 15th century, its scope 
and interests had been confined to the etiquette of physicians (5). 
Biomedical ethics was understood as a way of becoming a good 
doctor and taught to students of medicine in a form of ethical 
declaration. 
 But the sustainable development of medical ethics was inter-
rupted by the Japanese occupation (1910-1945) (6). Medical pro-
fessionals were urged to take a role of medical police to main-
tain surveillance of Koreans (7). Korea’s medical professionals, 
including the Korean Medical Association (KMA), struggled to 
restore the ethics tradition, but the result was not much to speak 
of. However, it is noteworthy that the importance of ethics was 
reiterated through several attempts to introduce ethics into med-
ical education. In 1964, the Geneva Declaration of the World 
Medical Association was translated and adopted among medi-
cal schools. In the early 1980s, the works of bioethics were intro-
duced to Korean academia, and medical schools adopted eth-
ics into their curricula (8).  
 The KMA developed the Doctor’s Code of Ethics, which was 
revised in 1961, 1965, 1979, 1997, and 2006. Through these revi-
sions, biomedical ethics remained a matter for the physician, 
not of public concern. As the application of the Code was com-
pelled by the authoritative regime during the 1960s and 1970s 
and related to the introduction of the National Health Insurance 
system in 1977, the social implications of medical practice be-
came recognized among medical professionals. 
Bioethics activists in Korea 
There is bioethics activism on the other side of medical ethics. 
This organized bioethics activism came to exist in the 1990s and 
concerned the abortion and end-of-life care issues (9). Activists 
expressed concerns from conservative perspectives on several 
health policies and demanded revision of legislation and, as a 
result, integrated biomedical ethics into healthcare policy. Inter-
estingly, many Korean bioethics academics held conservative 
perspectives on these issues, while researchers and medical 
practitioners represented the liberal position. 
Participants and their relationship in biomedical ethics 
discourse 
Medical professionals, researchers and engineers, biotechnolo-
gy entrepreneurs, bioethicists, and policy makers are possible 
participants in a biomedical ethics discourse. They are connect-
ed in various ways: monitor and review each other, regulate and 
control, mediate or co-work on certain issues. The modes can 
be passive and defensive or active and dominant. The major 
concerns for joining the bioethics discourse are preserving the 
identity of the groups, or realization of ideals shared among its 
members, sometimes promoting the interests. 
Biomedical ethics as a collective activity 
If we consider these two major participants of biomedical ethics, 
it seems persuasive that deliberations and building consensus 
are in conflict or negotiation between professionals and society, 
and regulators. This view could be named as “biopolitics”, not 
“bioethics”(10). However, bioethics should be viewed as a col-
lective activity between diverse perspectives to solve problems 
brought about during the struggle to improve human conditions 
by maintaining health and curing disease. Mistakes, understand-
ing and rectifying previous errors, are ways to progress (11). This 
is s pragmatic understanding of bioethics and will enable us to 
better open discussion. How does collective activity in bioethics 
work? In the field of bioethics, if there happens to be an ethical-
ly controversial case, this case pushes ethical questions to the 
fore, and public interest works as a launching place for academic 
interests. Afwter this issuing of a case, there follow professional 
responses that could be influenced by the decision made on that 
case: they appeal to the authority of traditional ethics or mean-
ing and imperatives of their professional values. The initial re-
sponses from professionals and their arguments and reasons 
become the subject of academic interests for further develop-
ment of argument. After this social discussion, or collective ac-
tivity, a resolution finally is derived in a form of court decision 
or legislation (12). By this collective activity, society can arrive 
at a better position for its members to live their life in its fullest 
sense. The cases of ethical disputes are not, in this sense, matters 
of conflict but chances for healthcare systems to embrace the 
values of society in general and to reflect on inconsistency in 
framing and solving health problems. Now that we can say that 
ethics is integral to health policy, then policy makers and bio-
medical ethics expert should develop a mechanism to specify 
and reflect the ethical discourse into practice: systematic and 
cultural transformations and legislations are possible answers. 
 
Healthcare policy and bioethics policy 
Even a very short reflection on the history of healthcare policy 
identifies numerous policies charged with ethical debates. But 
not until the 1990s, when organ transplantation and defining 
brain death became social issues, did ethics become a major 
concern for policy developers. Biomedical ethics became refer-
ence points and then targets of policy in itself. For example, eth-
ical principles (such as respect for autonomy) are expressed in 
the Framework Act on Health and Medical Services, and the gov-
ernment established public bodies like the Korean Network for 
Organ Sharing (KONOS) for ethical deliberations concerning 
the allocation of solid organs (13). 
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Events that shaped the field of biomedical ethics  
Biomedical ethics in Korea developed through major cases with 
deep social implications that led discourse. The following are 
cases that contributed to the development of the current bio-
medical ethics framework in Korea. 
Legislation of mother and child health act and anti-abortion 
campaign  
Mother and Child Health Act of 1973 contained provisions that 
identified legal conditions for pregnancy termination (i.e. abor-
tion), which had been provided as a part of family planning ser-
vices by the public health sector. There rarely was any public 
debate about the legitimacy of such legislation, but the acts or-
dered mandatory sterilization and abortion for eugenic pur-
poses. The act was revised to eliminate eugenic provisions, but 
the conditions for legitimate abortion remain with few changes. 
As a response to this legitimization of abortion, anti-abortion 
groups (mainly religious groups) formed organizations to pro-
test against the law, lobbying for banning almost every abortion 
and strict criminal punishments for illegal abortion (14). The 
major target for pro-life activists was not public awareness but 
rather strict enforcement. Meanwhile, the voices for women’s 
rights on self-determination and reproduction were relatively 
small, but obstetricians kept their understanding of abortion as 
a way to promote women’s health, and the government was loose 
in enforcement.  
 But the policy on population turned around in 2000’s, mainly 
due to rapid progression into an aging society, and the govern-
ment changed its attitude toward abortion. A governmental task 
force was formed to provide recommendations for preventing 
abortion. In 2009, the so-called “pro-life doctor” group imple-
mented a campaign against the government’s population poli-
cy and asked for strict punishments for abortion doctors (15). It 
was sensational for several reasons: professional groups became 
voluntarily engaged in public debate, and they asked for punish-
ment on their colleagues. 
 The abortion debate exemplifies the characteristic of Korean 
biomedical ethics discourse, that system such as legislation be-
comes target of criticism and change and that government’s po-
litical decision influence further discourse. There are not many 
academic discussions on the permissibility of abortion; public 
campaigns and political activities from the conservatives are 
still very active. 
Legislation of internal organs etc. transplant act (1999) 
and debate on brain death 
As transplantation techniques develop and more patients can 
be benefited with transplants, but organ selling and resulting 
dehumanization is brought about. Concerns about organ black 
markets and unequal access to transplantation led to legislation 
of the transplantation act in 1999. KONOS was established by 
law to ensure justice in allocation and monitoring and more rig-
orous monitoring for living organ donation was required on med-
ical practices (16). At the same time, legislation was intended 
for legalizing organ donations from brain-dead patients, which 
was demanded from transplantation surgeons (17). The first 
brain-dead donor transplantation took place in 1979, and by 
the year 1998 reported cases of brain death numbered 125, but 
there was no legal recognition of brain death. So surgeons had 
to take the risk of being accused of murder when they received 
consent from the attorney of the brain-dead patient for organ 
donation because these patients were not dead legally. Because 
brain death was not familiar to Korean society, and there was 
hesitation for lessening the standard of death, introduction of 
the brain death concept was barely possible (18). There was ad-
amant resistance that brain death could not be an alternative 
nor complementary concept for cardiac death. Legislators, who 
could not ignore the reality and necessity of donation from brain-
dead patients, reached a compromise: brain death should be 
decided by strict process and standards and organ donation 
could be permitted only after declaration of brain death (19).
 This dual recognition of brain death still remains in Korea and 
affects end-of-life care discourse. Because brain death does not 
constitute a standard of death, there exists a legal duty to care 
(usually life-sustaining treatment) for the brain-dead patient. 
When brain death is not recognized, other discussion about life-
sustaining treatment is difficult, not impossible (20). If ethical 
discussion and medical reality could not change public attitudes 
on death, there may be other facts to be explored. 
Boramae hospital case: medical convention not protected 
legally 
It took more than a decade to reach an agreement on foregoing 
life-sustaining treatment. There had been a convention of dis-
charging a patient with expectation of immediate death (so-called 
hopeless discharge) before the criminal case of Boramae Hospi-
tal (21). On December 4, 1997, a 58-yr-old-man fell on the floor 
at his house in a drunken state resulting in a massive intracra-
nial hemorrhage requiring surgery followed by intensive care 
unit administration. The patient’s wife learned from medical 
staff that the hematoma was removed through surgery and that 
her husband’s condition would improve. However, with power-
of-attorney, she insisted that her husband be discharged, citing 
financial burdens. Even though medical team told her that he 
would die without medical staff and a respirator, she signed a 
note, a form called discharge against medical advice (DAMA), 
and took her husband. In less than 5 min after leaving the hos-
pital, the patient died. When the authorities learned about the 
situation, both the wife and the hospital staff in charge were 
charged with homicide as joint offenders.
 On June 24, 2004, the Supreme Court sentenced the doctor to 
1 yr and 6 month in prison and 2 yr probation. The Court, while 
Hahm K-H and Lee I • Biomedical Ethics Policy in Korea
http://jkms.org  S79http://dx.doi.org/10.3346/jkms.2012.27.S.S76
acknowledging that the doctor had followed the demands of the 
guardian, asserted that he had permitted the patient to be dis-
charged although he knew that he would die without a respira-
tor (22). This judgment imposed the responsibility on the doc-
tor. This judgment came as a shock to most Korean doctors, as 
decisions of a patient’s family were generally accepted as an im-
portant ground for doctors in making difficult decisions regard-
ing treatment termination (23). With this judgment, doctors were 
reminded of their duties to treat patients as autonomous individ-
uals and the patients’ best interest should be considered under 
any circumstances. This led to the publication of the medical 
ethics guidelines but no explicit written provisions in laws, caus-
ing confusion, which became a social issue again in 2008 (24). 
 This shows a lack of communication between medical pro-
fessionals and society. 
Separation of dispensing function for prescribing  
Conflicts among doctors, pharmacists and the government re-
garding the separation of the dispensing function from prescrib-
ing provoked the doctors’ general strike of 2000 nationwide and 
became a national issue that roused much conflict and interest. 
Beginning with a one-day strike, it went on for five rounds, in 
addition to the nearly 4-month-long specialists’ strike.
 Doctors focused on banning alternative filling of prescriptions 
by pharmacists. However, under the circumstances in the med-
ical field back then, it was hardly possible and they were deter-
mined to block the implementation of the system itself.
 Despite doctors’ strong opposition, the government announced 
its stance to implement the system in September of 1998, with 
an exception for hospital in-patients, and passed the bill in the 
following year. This brought forth another strike among primary 
care physicians first and expanded into general strikes by doc-
tors thereafter.
 This event stemmed from the different views between the 
professionals’ interests and the government’s role over imple-
mentation of new policy. The fact that physicians, who stand 
conservative towards social issues, initiated a strong action like 
a general strike came to many people as a shock.
 It still remains to be seen whether this event will be seen by 
society as a fair protest for the justifiable rights of doctors or as 
an improper exercise of power. This provided a good opportu-
nity to debate society’s values regarding medicine and the med-
ical workers’ roles. However, doctors could not receive sympa-
thy from the public and failed to adhere to Article 8 of in the 
Declaration of Medical Ethics, thus bringing down the level of 
trust invested in them by the society. 
 Doctors tried to divert the source of public mistrust to the 
National Health Insurance System, not in the loss of profession-
alism among them. After 10 yr of the strike, public interruption 
and monitoring became more pervasive and less understand-
ing, such as stricter enforcement of anti-kickback provisions 
and introduction of license renewal (25). Ethics as a strategy to 
preserve professional autonomy is now facing serious mistrust 
from society, and other ethics is required. 
WS hwang research fraud 
WS Hwang’s renowned nuclear transfer stem cells (NTSC) was 
published in the Science. His method of NTSC was criticized 
that this technique could be used for human cloning, but Hwang 
evaded the debate by emphasizing the possible benefits from 
future NTSC applications. But in the year 2005, suspicions on 
his research practices, like his treatment of research assistants, 
as well as fabrications of 2004, 2005 research papers, exploded. 
He was found to have fabricated research results and deprived 
of his professor position from his university, and the aftermath 
of this scandal was huge (26).  
 Hwang’s research scandal vividly reminded Korean society 
of the ethical nuances in scientific research, leading to estab-
lishing ethics reviewing systems. Legislation of Bioethics and 
Safety Act (2005) was initiated by the debate about the ethics of 
Hwang’s research. The Korea National Bioethics Board and in-
stitutional bioethics boards are grounded on this act, and stem 
cell researches, human genetic research and other research us-
ing human embryo are under the regulation of this act (27). 
 But the most important lesson from this case was the serious-
ness of research integrity among Korean researchers. The Min-
istry of Education, for example, issued a directive that every in-
stitution benefitting from governmental R&D funds should in-
stall a body to review research integrity (28). 
Severance hospital case 
In February 2008, a 77-yr-old female suffered hypoxic brain 
damage due to severe bleeding from a pulmonary artery during 
a bronchoscope biopsy. Soon thereafter, she was diagnosed as 
persistent vegetative state (PVS) and could not breathe by her-
self. Her family wanted to withdraw the life-sustaining treatment 
(artificial ventilator) and let her die in a dignified way as she had 
expressed before, but medical staff argued that she could sur-
vive quite a significant period of time and that the treatment 
should continue. A lawsuit to stop medical treatment was insti-
tuted and the so-called severance hospital case began. The trial 
process was quick, and the Supreme Court ruled: 
 “when it is recognized that a patient who reached a state of 
irreversible stage of death exercise her right to self determina-
tion on the ground of constitutional rights of human dignity and 
right to pursue happiness, it is permissible to withdraw life-sus-
taining treatment” (29). 
 Despite the serious ethical discourse about end-of-life care 
following the Boramae Hospital case in 1997, mechanisms such 
as advance directive, durable power of attorney, and clinical 
ethics consultation had not been implemented properly. So, 
many professional bodies like the KMA and Korean Hospital 
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Association were quick to develop legitimate guidelines to real-
ize the spirit of the court decision (30). A citizens’ campaign for 
writing advance directives was launched to mobilize and revi-
talize preparing end-of-life care planning. Meanwhile, the med-
ical professional’s recognition or participation does not reach 
the expectation. There can be several reasons, but they seem to 
demand more secure basis for following patient’s will, like exemp-
tion from liability (31). The controversies may continue before 
reasonable conditions or processes for withdrawing be given.
DISCUSSION AND SUGGESTIONS 
Biomedical ethics is not a single way of communication. It is 
between conflicting perspectives of the liberal and the conser-
vative, ethical specialists and policy makers, and even between 
disciplines. The communication is not to defeat the other side 
with political tactics, but a collective way of reaching common 
understanding and solutions to a problem. 
 Medical science and healthcare are dealing human life and 
health, which are the very foundation of all human activities 
and closely connected with values. Values are to the subject of 
ethical discourse, which is to bring up an applicable and reason-
able solution to current ethical problems. Ethical discourse is 
collaborative in its nature, which means every participant con-
tributes to generation of applicable solution. Governmental pol-
icies are developed as a result of social measure to problems and 
also means for society to sustain its common ground between 
different values. But the policies sometimes bring about another 
tension rather than cooperation when they are not based on 
sufficient communication. We can see it in the case of the abor-
tion debate. When participants do not focus on practicable so-
lution but repeat their own agenda, the solution would be too 
far to reach. We equipped, by legitimate process, the legislation 
about abortion but participants of the debate do not respect it. 
Why? The legislation is only temporary remedy without social 
acceptance. 
 Legislation or policy initiative gives effectiveness and contin-
uation that secure the product of ethical discourse. Ethical solu-
tions can take various forms like guidelines or position state-
ments, but sometimes discussion itself is sufficient even with-
out any products. Ethics works through exchanging and under-
standing the perspectives of other persons toward a common 
understanding and consensus. Legislation could be abused as 
a bypass to avoid social discussion and consensus. And if we 
become too dependent on any law, some issues placed in the 
blind spot of law are readily neglected. 
 Following will be necessary for Korean society to adjust itself 
to the ethical changes. First, we must make it anew the under-
standing that medical ethics is collaboration, not conflict. Par-
ticipation, expressing of the concerns, developing common un-
derstanding, and resourceful identification of solution is key to 
the collaboration. Second, the field for sustainable and produc-
tive debate/discussion should be provided. Governmental sup-
porting for ethics research institutes needs to be increased espe-
cially to educating medical ethics experts who is knowledgeable 
to medicine and ethical-legal discipline. And the institutes can 
provide the experiences of successful debate and win-win solu-
tion. They will deepen the commitment to joint activity, but it 
will take time to have this kind of experiences. In the example of 
biomedical ethics discourse of other countries, biomedical eth-
ics institutions are taking the role of communication linkage. For 
example, Singapore and United States have national bioethics 
committees appropriate for their culture and current problems, 
and while US developed independent, but institution-based 
ethics bodies (i.e. IRB) as basic units of ethical review, other na-
tions such as the United Kingdom or Australia have installed 
public ethical review bodies. Third, in the organizational level, 
legally designated committees should be revitalized and effi-
cient in its deliberation with more discretion. It needs providing 
the well-trained personnel who understand the interdisciplin-
ary character of ethics, and have experiences of running a com-
mittee. Policy initiatives from government, research funding 
organizations and national health insurance can affect its de-
velopment. Finally vigorous communication and educating the 
public on biomedical issues and its ethical implications is im-
perative, for common understanding of social and scientific 
fact is basis for any consensus (32). 
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